Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
2.190
-0.370 (-14.45%)
At close: Apr 7, 2026, 4:00 PM EDT
2.360
+0.170 (7.76%)
After-hours: Apr 7, 2026, 7:54 PM EDT
Galectin Therapeutics Employees
Galectin Therapeutics had 15 employees as of December 31, 2024. The number of employees increased by 1 or 7.14% compared to the previous year.
Employees
15
Change (1Y)
1
Growth (1Y)
7.14%
Revenue / Employee
n/a
Profits / Employee
-$2,064,933
Market Cap
144.16M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 15 | 1 | 7.14% |
| Dec 31, 2023 | 14 | 2 | 16.67% |
| Dec 31, 2022 | 12 | 3 | 33.33% |
| Dec 31, 2021 | 9 | 3 | 50.00% |
| Dec 31, 2020 | 6 | 2 | 50.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Employee RankingsGALT News
- 3 months ago - GALT Investors Have Opportunity to Join Galectin Therapeutics Inc. Fraud Investigation with the Schall Law Firm - GlobeNewsWire
- 3 months ago - GALT Investors Have Opportunity to Join Galectin Therapeutics Inc. Fraud Investigation with The Schall Law Firm - Business Wire
- 5 months ago - Galectin Therapeutics Reports Financial Results for the quarter ended September 30, 2025, and Provides Business Update - GlobeNewsWire
- 7 months ago - Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 11 months ago - Galectin Therapeutics Presented NAVIGATE Trial Results at the European Association for the Study of the Liver (EASL) 2025 Congress - GlobeNewsWire
- 1 year ago - Galectin Therapeutics Reports 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 1 year ago - Galectin Therapeutics to Present at the 2025 MASH-TAG Conference - GlobeNewsWire
- 1 year ago - Why Is Small Cap Galectin Therapeutics Stock Trading Lower On Friday? - Benzinga